{"database": "lobbying", "table": "lobbying_activities", "rows": [[3801742, "5ad581d1-e060-4fd9-b402-66991b7a5e37", "Q1", "ELITE STRATEGIC SERVICES", 401108852, "CONSERVATIVES FOR PROPERTY RIGHTS", 2026, "first_quarter", "TRD", "Special 301 Report - bolstering U.S. advocacy abroad for respecting intellectual property rights U.S. Trade Representative Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation (Docket No. USTR-2025-0011) Employ robust trade policies and pressure tactics to cudgel foreign freeloaders to to stop using drug pricing disparities as a nontariff trade barrier and begin paying their fair share-actual market value-for U.S. medicines U.S. Trade Representative Request for Comments on the Operation of the Agreement between the United States of America, the United Mexican States, and Canada (Docket No. USTR-2025-0004) Urging pursuit in ongoing trade negotiations to ensure Japanese biopharma price controls do not thwart American medical innovation in global markets", "HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR)", 25000, null, 0, 0, "2026-04-01T15:25:31-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3801742"], "units": {}, "query_ms": 0.4659120459109545, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}